Compare Funds

Detailed comparison on parameters like NAV | Returns | Risk | Rating | Analysis

Nippon India Pharma Fund Direct Growth

Equity
Sectoral / Thematic
3.0

SBI Healthcare Opportunities Fund Direct Plan Growth

Equity
Sectoral / Thematic
5.0

Add a fund

Nippon India Pharma Fund Direct Growth

(43.2%)

SBI Healthcare Opportunities Fund Direct Plan Growth

(39.4%)
1Y
3Y
5Y
Fund Details
RiskVery HighVery High-
Min SIP Amount₹100₹500-
Expense Ratio0.93%0.94%-
NAV₹508.6 (12-Jul-2024)₹415.5 (12-Jul-2024)-
Fund Started31-Dec-201201-Jan-2013-
Fund Size₹7,404Cr₹2,760Cr-
Exit LoadExit load of 1% if redeemed within 1 month.Exit load of 0.50% if redeemed within 15 days-
Returns
1Y
43.2%
39.4%
-
3Y
15.3%
17.6%
-
5Y
27.6%
28.8%
-
Pros & Cons
Pros
1.3Y, 5Y and 10Y annualised returns higher than category average
2.Lower expense ratio: 0.93%
1.Lower expense ratio: 0.94%
2.3Y, 5Y and 10Y annualised returns higher than category average
-
Cons
1.1Y annualised returns lower than category average by 1.99%
1.1Y annualised returns lower than category average by 4.02%
-

Holding Analysis

Top 5
-
-
-
Top 20
-
-
-
P/E
-
-
-
P/B
-
-
-
Turnover
-
-
-
Equity
-
-
-
Cash
-
-
-

Top Holdings

Top 10 Holdings
Name
Assets
Sun Pharmaceutical Industries Ltd.
13.5%
Divi's Laboratories Ltd.
8.4%
Lupin Ltd.
7.7%
Cipla Ltd.
6.2%
Dr. Reddy's Laboratories Ltd.
6.0%
Apollo Hospitals Enterprise Ltd.
5.4%
Zydus Lifesciences Ltd.
3.9%
Gland Pharma Ltd.
3.7%
Abbott India Ltd.
3.2%
Vijaya Diagnostic Centre Ltd.
3.2%
Name
Assets
Sun Pharmaceutical Industries Ltd.
13.8%
Max Healthcare Institute Ltd.
7.7%
Divi's Laboratories Ltd.
6.7%
Cipla Ltd.
6.7%
Lonza Group Ag
4.9%
Aether Industries Ltd.
4.7%
Jupiter Life Line Hospitals Ltd.
4.1%
Aurobindo Pharma Ltd.
3.9%
Mankind Pharma Ltd.
3.9%
Krishna Institute of Medical Sciences Ltd
3.8%
-
Fund Manager
Name
Sailesh Raj Bhan
Tanmaya Desai
-
Education
Mr. Bhan is an MBA (Finance) and CFA.
Mr. Desai is a B.E. (Electronics), MBA (Finance) and CFA (Level III).
-
Experience
Prior to joining Nippon India Mutual Fund, he has worked with Emkay Share & Stock Broker Pvt. Ltd, Shah & Sequeira Invst. Pvt. Ltd, ICFAI- Securities Research Center Analyst - Equity Research.
Prior to joining SBI Mutual Fund he has worked with D.J. Sanghvi College of Engineering and Patni Computer Systems Ltd.
-
About Fund
Description

Reliance Mutual Fund started their mutual fund on 30/06/1995 and its managing total assets of ₹2,32,169 Cr. Its ranked at 3 as per total assets at end of 30th Sep 2017.

SBI Mutual Fund started their mutual fund on 29/06/1987 and its managing total assets of ₹1,88,455 Cr. Its ranked at 5 as per total assets at end of 30th Sep 2017.

-

Launch Date

30 Jun 1995

29 Jun 1987

-

Custodian

Deutsche Bank

SBI SG Global Securities Services Pvt.Ltd.

-

Registrar & Transfer Agent

KFin Tech

Cams

-

Popular Comparisons

Motilal Oswal Multicap 35 Fund - Direct - Growth
Vs
SBI Flexicap Fund Direct Growth
Axis Bluechip Fund - Direct - Growth
Vs
SBI Bluechip Fund - Direct - Growth
HDFC Small Cap Fund - Direct - Growth
Vs
HSBC Small Cap Fund Direct Growth
ⓒ 2016-2024 Groww. All rights reserved, Built with in India
MOST POPULAR ON GROWWVERSION - 5.1.2
STOCK MARKET INDICES:  S&P BSE SENSEX |  S&P BSE 100 |  NIFTY 100 |  NIFTY 50 |  NIFTY MIDCAP 100 |  NIFTY BANK |  NIFTY NEXT 50
MUTUAL FUNDS COMPANIES:  GROWWMF |  SBI |  AXIS |  HDFC |  UTI |  NIPPON INDIA |  ICICI PRUDENTIAL |  TATA |  KOTAK |  DSP |  CANARA ROBECO |  SUNDARAM |  MIRAE ASSET |  IDFC |  FRANKLIN TEMPLETON |  PPFAS |  MOTILAL OSWAL |  INVESCO |  EDELWEISS |  ADITYA BIRLA SUN LIFE |  LIC |  HSBC |  NAVI |  QUANTUM |  UNION |  ITI |  MAHINDRA MANULIFE |  360 ONE |  BOI |  TAURUS |  JM FINANCIAL |  PGIM |  SHRIRAM |  BARODA BNP PARIBAS |  QUANT |  WHITEOAK CAPITAL |  TRUST |  SAMCO |  NJ